Skip to content
buyWeak

ADAR1 Capital Management, LLC bought $14k of INM

owner at InMed Pharmaceuticals Inc.. 10,903 shares at an average of $1.33, traded Oct 6, 2026, filed Oct 8, 2026.

Conviction score
12
Value
$14k
10,903 shares
Holdings after
945,924
+1% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    10% owner
    +12
  • Trade size
    $14k at market
    0
  • Relative to holdings
    Holdings up 1.2%
    0
  • Price context
    No price history yet
    0
  • Cluster
    No other insider buying within 14 days
    0
  • Repeat buying
    3 buys in 90 days
    +5
  • Track record
    Too few past buys to judge (0 with prices)
    0
  • Outside holder
    A 10% owner who is not an officer or director
    -5

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

INMOct 9, 2026 · close 1.36
Since filing Oct 8, 2026: +2.3%SPY +0.6% · excess +1.7%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001940272-26-000023, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Oct 6, 2026POpen-market purchase
Common Sharesindirect: See Footnote
+5,601$1.33$7,436940,6224 d ago
Oct 7, 2026POpen-market purchase
Common Sharesindirect: See Footnote
+3,046$1.33$4,051943,6684 d ago
Oct 8, 2026POpen-market purchase
Common Sharesindirect: See Footnote
+2,256$1.33$2,997945,9244 d ago

Related signals

Other insiders at InMed Pharmaceuticals Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
19Weak
INMbuy
InMed Pharmaceuticals Inc.
ADAR1 Capital Management, LLC
owner
$57k
42,920 shares
+5%
20Weak
INMbuy
InMed Pharmaceuticals Inc.
ADAR1 Capital Management, LLC
owner
$118k
91,101 shares
+11%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

ADAR1 Capital Management, LLC bought $14k of INM | InsiderTell